v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net loss $ (14,123) $ (33,981)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 3,707 2,242
Stock-based compensation expense 8,042 7,469
Loss on fixed asset disposal 6 0
Provision for estimated credit losses 486 (148)
Accretion (amortization) of discounts (premiums) on marketable securities, net 18 (460)
Change in fair value of contingent consideration and derivative liability 223 69
Changes in operating assets and liabilities:    
Accounts receivable 1,032 3,860
Contract assets (1,620) (344)
Prepaid expenses and other current assets (604) (908)
Other assets 319 201
Accounts payable (1,565) (630)
Accrued expenses and other current liabilities (6,596) (18,752)
Accrued income taxes (1,439) (4,370)
Deferred revenue (4,307) 2,127
Other non-current liabilities (877) 126
Net cash used in operating activities (17,298) (24,430)
Cash flows from investing activities:    
Sales of marketable securities 0 29,752
Maturities of marketable securities 1,000 34,900
Acquisition of businesses 0 (32,879)
Purchases of property and equipment (21) (580)
Net cash provided by investing activities 979 31,193
Cash flows from financing activities:    
Proceeds from issuance of common stock 12,193 361
Payments of equity issuance costs (606) 0
Proceeds from issuance of convertible note 10,000 0
Payment of payroll taxes related to shares withheld from employees (307) (1,294)
Payments of contingent consideration (104) (46)
Payments of vendor financing obligation 0 (1,259)
Net cash provided by (used in) financing activities 21,176 (2,238)
Effect of exchange rate fluctuations on cash and cash equivalents (101) 189
Net increase in cash, cash equivalents and restricted cash 4,756 4,714
Cash, cash equivalents, and restricted cash, beginning of period 17,258 19,606
Cash, cash equivalents, and restricted cash, end of period 22,014 24,320
Cash and cash equivalents 22,014 11,945
Restricted cash 0 12,375
Total cash, cash equivalents and restricted cash 22,014 24,320
Noncash investing and financing activities:    
Issuance of derivative liability in connection with convertible note 3,205 0
Nonrelated Party    
Adjustments to reconcile net loss to net cash used in operating activities:    
Litigation settlement 0 13,069
Related Party    
Adjustments to reconcile net loss to net cash used in operating activities:    
Litigation settlement $ 0 $ 6,000